183 related articles for article (PubMed ID: 31493232)
1. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.
Cui F; Qu D; Sun R; Nan K
Med Oncol; 2019 Sep; 36(10):84. PubMed ID: 31493232
[TBL] [Abstract][Full Text] [Related]
2. The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment.
Cui F; Qu D; Sun R; Tao H; Si J; Xu Y
Dis Markers; 2019; 2019():7152183. PubMed ID: 31636738
[TBL] [Abstract][Full Text] [Related]
3. Mass Cytometry Reveals a Sustained Reduction in CD16
Shinko D; McGuire HM; Diakos CI; Pavlakis N; Clarke SJ; Byrne SN; Charles KA
Front Immunol; 2019; 10():2584. PubMed ID: 31749810
[TBL] [Abstract][Full Text] [Related]
4. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2019 Feb; 197(1):53-60. PubMed ID: 30523401
[TBL] [Abstract][Full Text] [Related]
6. Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.
Jabir NR; Firoz CK; Ahmed F; Kamal MA; Hindawi S; Damanhouri GA; Almehdar HA; Tabrez S
Immunol Invest; 2017 Jul; 46(5):526-535. PubMed ID: 28414590
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer.
Yin M; Di G; Bian M
Int Immunopharmacol; 2018 Nov; 64():333-339. PubMed ID: 30243069
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.
Zhou C; Wang Z; Jiang B; Di J; Su X
Front Immunol; 2022; 13():807539. PubMed ID: 35185893
[TBL] [Abstract][Full Text] [Related]
9. A population of atypical CD56(-)CD16(+) natural killer cells is expanded in PTSD and is associated with symptom severity.
Bersani FS; Wolkowitz OM; Milush JM; Sinclair E; Eppling L; Aschbacher K; Lindqvist D; Yehuda R; Flory J; Bierer LM; Matokine I; Abu-Amara D; Reus VI; Coy M; Hough CM; Marmar CR; Mellon SH
Brain Behav Immun; 2016 Aug; 56():264-70. PubMed ID: 27025668
[TBL] [Abstract][Full Text] [Related]
10. Changes in subset distribution and impaired function of circulating natural killer cells in patients with colorectal cancer.
Zu S; Lu Y; Xing R; Chen X; Zhang L
Sci Rep; 2024 May; 14(1):12188. PubMed ID: 38806640
[TBL] [Abstract][Full Text] [Related]
11. Recovery of NK(CD56+CD3-) Cells after One Year of Tenofovir Therapy for Chronic Hepatitis B Infection.
Lee HH; Kang H; Cho H
J Microbiol Biotechnol; 2017 Jun; 27(6):1204-1308. PubMed ID: 28335588
[TBL] [Abstract][Full Text] [Related]
12. Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy.
Oppenheim DE; Spreafico R; Etuk A; Malone D; Amofah E; Peña-Murillo C; Murray T; McLaughlin L; Choi BS; Allan S; Belousov A; Passioukov A; Gerdes C; Umaña P; Farzaneh F; Ross P
Br J Cancer; 2014 Mar; 110(5):1221-7. PubMed ID: 24496456
[TBL] [Abstract][Full Text] [Related]
13. [Results of the treatment in selected infertile patients with high density of endometrial NK cells CD56+ and CD16+ Second part].
Ulčová-Gallová Z; Pešek M; Haschová M; Chaloupka P; Mukenšnabl P; Cibulka J; Lošan P; Bibková K; Mičanová Z
Ceska Gynekol; 2018; 83(2):115-118. PubMed ID: 29869509
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of intraportal chemotherapy on natural killer cell activity in colorectal cancer patients.
Rafique M; Adachi W; Koike S; Kajikawa S; Yazawa K; Sugenoya A; Amano J
J Surg Oncol; 1997 Apr; 64(4):324-30. PubMed ID: 9142191
[TBL] [Abstract][Full Text] [Related]
16. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
[TBL] [Abstract][Full Text] [Related]
17. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
18. Expanded CD56
Poznanski SM; Nham T; Chew MV; Lee AJ; Hammill JA; Fan IY; Butcher M; Bramson JL; Lee DA; Hirte HW; Ashkar AA
Cancer Immunol Res; 2018 Oct; 6(10):1174-1185. PubMed ID: 30018043
[TBL] [Abstract][Full Text] [Related]
19. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
20. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
